- Hiring from
- Germany
- Work type
- Hybrid
- Posted
623,273 remote jobs, straight from company career pages
100% free · New jobs every minute
Show job descriptionHide job description
About Evumed
Evumed Limited is a forward-thinking generics and biopharmaceutical company headquartered in Cork, Ireland, established as the European arm of a global pharmaceutical platform. Through our parent company and global partnerships, we develop and deliver generic, branded, and biologic medicines, bringing innovation and accessibility together to improve lives.
At Evumed, we are committed to delivering high-quality, accessible medicines across Europe by leveraging our global manufacturing and regulatory footprint.
About the Role
We are seeking an experienced Sales & Market Access Director to lead the successful commercial launch and market access execution of Evumed's Diabetes franchise in Germany. Reporting to the Evumed President, this role will be responsible for developing and executing commercial and market access strategies, building key stakeholder relationships, creating sales growth opportunities, delivering topline growth and market share according to budgets and establishing Evumed as a trusted partner within the German healthcare ecosystem.
The successful candidate will possess deep expertise within the German life sciences sector particularly within diabetes and insulin therapy, combined with a strong network of payer, pharmacy, physician, wholesaler, procurement, and reimbursement stakeholders. This individual will play a critical role in securing market access, driving product uptake, and establishing the commercial foundation for future portfolio expansion. Evumed is expanding across Europe with ambitious plans to replicate the success of our sister company, Meitheal, in the United States.
Key Responsibilities
Commercial Strategy & Execution
- Lead the commercialisation of Evumed's Diabetes portfolio in Germany, delivering market access and sustainable revenue & profitability growth.
- Identify, secure and convert market opportunities for future biosimilar launches.
- Analyse competitive activity and market developments to capture market opportunities.
- Provide strategic market insights to European leadership.
Market Access Leadership
- Lead market access strategy and execution for Evumed products within Germany.
- Design and win reimbursement approvals, tender awards and commercial agreements that accelerate product uptake and revenue growth.
- Develop and maintain relationships with key payer organizations, sickness funds, procurement groups, pharmacy buying organizations, wholesalers, and all kind of reimbursement stakeholders.
- Develop compelling value propositions and market access materials for external stakeholders.
- Drive market access strategies and evidence-generation initiatives to secure reimbursement, accelerate patient access and strengthen commercial performance.
Sales Leadership
- Build, lead, and develop a high-performing sales organization aligned to business needs.
- Drive excellence in customer execution and field force effectiveness.
- Foster a high-performance culture focused on accountability, collaboration, and customer focus.
Business Planning & Performance Management
- Support development of annual operating plans, forecasts, and own commercial budgets.
- Monitor business performance against agreed targets and KPIs.
Compliance & Governance
- Ensure all commercial activities are conducted in compliance with German regulations, industry codes, and company policies.
- Maintain strong governance standards across sales and market access activities.
- Work closely with Evumed European Regulatory Affairs, Medical Affairs, Supply Chain, and Commercial leaders to ensure coordinated market execution.
Qualifications and Experience
Required
- Bachelor's Degree in Life Sciences, Pharmacy, Business, Economics, Healthcare Management, or related discipline.
Preferred
- MBA or other relevant postgraduate qualification.
Language Requirements
- Native or fluent German.
- Fluent English.
Experience and personal Attributes
- Significant commercial leadership experience within the German pharmaceutical industry.
- Proven track record of delivering market share growth and revenue expansion in highly competitive pharmaceutical markets, preferably within generics, biosimilars, or diabetes care.
- Demonstrated success building and scaling a pharmaceutical business in Germany, including market entry, commercial team development, and securing initial customer and payer agreements.
- Strong expertise in the German insulin and diabetes market, including prescribing, reimbursement, distribution, and procurement dynamics.
- In-depth understanding of German healthcare funding, pricing, reimbursement, tendering, and market access frameworks.
- Proven ability to secure market access, reimbursement, and commercial agreements with payers, procurement bodies, and key healthcare customers.
- Established network and strong relationships with major customers, sickness funds, procurement organizations, pharmacy groups, and healthcare decision-makers.
- Excellent commercial negotiation, influencing, and stakeholder management skills, with the ability to operate credibly at senior executive and industry levels.
- Entrepreneurial approach with the ability to operate effectively within a growth environment
Work Environment
Hybrid working model potentially based in Munich or Frankfurt.
Frequent travel throughout Germany to engage customers, payers, pharmacy organizations, procurement stakeholders, healthcare professionals, and key opinion leaders, together with periodic travel across Europe. Could Mention to Company Car, fuel card etc – is it mandatory in Germany
Success Measures (First 24 Months)
Year 1
- Successful commercial launch of Evumed's Diabetes portfolio.
- Establishment of key payer, reimbursement, and procurement relationships.
- Achievement of agreed sales objectives and launch milestones.
- Recruitment and development of an effective commercial team where required.
- Development of strong visibility and recognition for Evumed within relevant stakeholder groups.
Year 2
- Sustainable growth in insulin market share.
- Increased customer adoption and account penetration.
- Expansion of market access agreements and stakeholder partnerships.
- Creation of a scalable commercial platform capable of supporting future biosimilar launches.
- Delivery of agreed sales, market share, and profitability objectives.
